Observational study of kidney disease patients in China
China Kidney Patient Trials Network
This study is trying to learn more about how kidney diseases progress and are managed by following patients in China who have been diagnosed with these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1200 (estimated) |
| Ages | 2 Years and up |
| Sex | All |
| Sponsor | Emerald Clinical Inc. Industry-sponsored |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT05036850 on ClinicalTrials.gov |
What this trial studies
This observational cohort study aims to gather data on both new and existing patients diagnosed with various kidney diseases in China. It will involve regular follow-ups with participants who meet specific eligibility criteria, including a documented diagnosis and a minimum eGFR level. The study seeks to understand the progression and management of kidney diseases, contributing valuable insights to the field. By collecting comprehensive data, the study hopes to inform future interventional research.
Who should consider this trial
Good fit: Ideal candidates include individuals aged 2 years and older with a documented diagnosis of primary kidney disease and an eGFR greater than 15 ml/min/1.73 m2.
Not a fit: Patients with a life expectancy of less than 6 months will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of kidney disease progression and improve patient management strategies.
How similar studies have performed: While observational studies on kidney diseases are common, the specific approach and focus of this study may provide novel insights into patient management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Documented diagnosis of primary kidney disease 2. Regular visits (at least 6 monthly) with a physician at a participating site 3. eGFR \> 15 ml/min/1.73 m2 4. ≥ 2 years of age 5. Willing and able to sign informed consent 6. Willing to be approached about participation in interventional research studies Exclusion Criteria: * 1\. Life-expectancy of less than 6 months
Where this trial is running
Beijing, Beijing Municipality
- George Clinical (Beijing) — Beijing, Beijing Municipality, China (Recruiting)
Study contacts
- Study coordinator: FanHan Hsu
- Email: CKPTN@georgeclinical.com
- Phone: +61 2 8052 4300
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.